GSK1360707
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK1360707, covering 2017-06-27 to 2017-06-27. Get the full timeline:
Most recent: Clinical Trial Update: An Open Label Positron Emission Tomography Study in Healthy Male Subjects to Investigate Brain DAT and SERT Occupancy,Pharmacokinetics and Safety of Single Oral Doses of GSK1360707, Using 11C- PE2I and 11C-DASB as PET Ligands [Phase 1]